Henry Schein (NASDAQ:HSIC) Raised to Hold at BMO Capital Markets

Henry Schein (NASDAQ:HSIC) was upgraded by investment analysts at BMO Capital Markets to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

A number of other equities research analysts have also recently issued reports on HSIC. Citigroup began coverage on shares of Henry Schein in a research report on Wednesday, April 15th. They set a “buy” rating and a $100.00 target price for the company. Robert W. Baird set a $97.00 price target on shares of Henry Schein in a research report on Wednesday, May 6th. UBS Group reaffirmed a “neutral” rating and set a $85.00 price objective (down from $87.00) on shares of Henry Schein in a research note on Wednesday, May 6th. Morgan Stanley reaffirmed an “underweight” rating and set a $64.00 price objective (up from $61.00) on shares of Henry Schein in a report on Friday, April 24th. Finally, Mizuho cut their target price on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $87.64.

Henry Schein Price Performance

Shares of HSIC stock opened at $83.86 on Wednesday. The stock’s fifty day simple moving average is $77.83 and its 200 day simple moving average is $77.29. Henry Schein has a one year low of $61.94 and a one year high of $89.29. The firm has a market cap of $9.55 billion, a price-to-earnings ratio of 25.34, a P/E/G ratio of 1.60 and a beta of 0.81. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.36 and a quick ratio of 0.75.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.12. The firm had revenue of $3.37 billion during the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.15 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, analysts expect that Henry Schein will post 5.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director William K. Daniel acquired 10,000 shares of the stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the transaction, the director owned 20,000 shares of the company’s stock, valued at $1,383,800. The trade was a 100.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.89% of the company’s stock.

Institutional Trading of Henry Schein

Hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC raised its position in Henry Schein by 47.3% in the 1st quarter. AQR Capital Management LLC now owns 30,402 shares of the company’s stock worth $2,071,000 after purchasing an additional 9,756 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Henry Schein by 1.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock valued at $1,155,000 after buying an additional 229 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Henry Schein in the 1st quarter valued at $676,000. Cetera Investment Advisers increased its stake in shares of Henry Schein by 12.9% in the 2nd quarter. Cetera Investment Advisers now owns 5,561 shares of the company’s stock valued at $406,000 after buying an additional 637 shares during the period. Finally, First Trust Advisors LP raised its position in shares of Henry Schein by 0.8% during the second quarter. First Trust Advisors LP now owns 221,130 shares of the company’s stock worth $16,154,000 after acquiring an additional 1,669 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.